rxstat › Shortages › Iohexol

Iohexol shortage status

Shortage anticipated

Source: Health Canada shortage reports · Updated Jul 9, 2026

A shortage of Iohexol is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.
Products affected
0 of 4
Reports on file
53

Reports by product

Anticipated
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · Other (Please describe in comments)
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Jun 6, 2025 · Demand increase for the drug.
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended May 23, 2025 · Demand increase for the drug.
Resolved
OMNIPAQUE 350
755MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172755 · ended May 2, 2025 · Other (Please describe in comments)
Resolved
OMNIPAQUE 350
755MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172755 · ended Apr 28, 2025 · Delay in shipping of the drug.
Resolved
OMNIPAQUE 300
647MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172747 · ended Apr 21, 2025 · Delay in shipping of the drug.
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Mar 3, 2025 · Other (Please describe in comments)
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Sep 27, 2024 · Demand increase for the drug.
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Sep 20, 2024 · Demand increase for the drug.
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Jun 11, 2024 · Demand increase for the drug.
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended May 3, 2024 · Demand increase for the drug.
Resolved
OMNIPAQUE 240
518MG · SOLUTION · GE HEALTHCARE CANADA INC
DIN 02172739 · ended Apr 1, 2024 · Demand increase for the drug.

Showing 12 of 53 reports. All reports are on file with Health Canada.

What's happening

A manufacturer has told Health Canada it expects supply of Iohexol to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.

Iohexol is classified under “X-RAY CONTRAST MEDIA, IODINATED” (ATC V08AB).

Recent changes

Common questions

When will Iohexol be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Iohexol in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (x-ray contrast media, iodinated)

Widespread shortageIoversol2 of 2 reported products affectedPartial shortageMeglumine Iodipamide1 of 1 reported products affectedNo current shortageIopamidolNo current shortageIopromideNo current shortageIothalamate Meglumine

All x-ray contrast media, iodinated shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.